About US
Contact us
-
3SBio signs exclusive license agreement with JenKem for PEG-irinotecan3SBio Inc., ("3SBio") a leading biotechnology company based in China focusing on researching, developing, manufacturing and marketing biopharmaceutical products, announced today that it has entered in2014/9/26
-
IGI Laboratories acquires regulatory rights for 18 drug products from AstraZenecaIGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has acquired the regulatory rights and related documents and records for 18 drug2014/9/26
-
Micron Technologies to Exhibit at CPhIMicron Technologies is pleased to invite you to its booth 6P130 at the forthcoming CPhI Paris 2014. Micron Technologies provides contract particle size reduction and analytical services for the pharm2014/9/25
-
Meet Softigel by Procaps at CPhISoftigel by Procaps will be attending CPhI Worldwide in Paris from 7-9 October, where our team of experts will be available to discuss mutual opportunities. Softigel by Procaps offers product develop2014/9/25
-
UK researchers discover new gene responsible for serious respiratory infectionsResearchers from the University College London have discovered a new gene associated to a rare disease, which induces respiratory problems similar to cystic fibrosis. Primary ciliary dyskinesia (PCD)2014/9/25
-
Chinese study of serogroup 6 S. pneumoniae finds no antibiotic-resistant clonesBy Joanna Lyford, Senior medwireNews Reporter A survey of serogroup 6Streptococcus pneumoniaeisolates from children in China has identified no antibiotic-resistant clones, leading the authors to spec2014/9/24
-
Merck to buy Sigma-Aldrich for $17bnUS-based Merck has signed an agreement to acquire Sigma-Aldrich for $17bn (€13.1bn), which will boost the company's position in the life science industry.Under the deal, Merck will acquire all outstan2014/9/24
-
AstraZeneca’s Movantik receives FDA approval to treat OICAstraZeneca has received approval from the US Food and Drug Administration (FDA) for its Movantik (naloxegol) tablets C-II to treat opioid-induced constipation (OIC) in adult patients with chronic non2014/9/24
-
Gilead’s Zydelig gets marketing approval from European Commission for incurable blood cancersUS-based Gilead Sciences has received marketing authorisation from the European Commission for its Zydelig (idelalisib) 150mg tablets to treat two incurable blood cancers, chronic lymphocytic leukemia2014/9/23
-
Sun Pharma and Merck partner for plaque psoriasis drug candidate tildrakizumabIndia-based Sun Pharma has signed an exclusive worldwide licensing agreement with US-based Merck for its investigational therapeutic antibody candidate, tildrakizumab (MK-3222). Tildrakizumab is a hu2014/9/23